Effect of eye oleation and stimulation of vital energy points in Myopia.

Phase 2/3

Recruiting

• Conditions: patient having discomfort in distant vision

• Registration Number: CTRI/2017/08/009353
• Lead Sponsor: Rishikul Campus UAU

Brief Summary

*Timira* is one of the *Drishtigata* *Rogas* whichis said to be a *Paramdarun* *vyadhi*, because it is a progressivedisease which invades Patalas in progressive nature and ultimately ends inblindness. On the basis of clinical feature of *Timira* described in texts*Prathama Patalagata* *Timira* can be correlated with myopia. Myopiais a common refractive error in which one can see near objects clearly, butobjects farther away are blurred. Prevalence of myopia is increasing now a day.In India its prevalence in general population is reported to be 6.9%. Treatmentmodalities include eyeglasses, contact lenses and refractive surgery. But thereare certain precincts that give way to *Ayurveda* to treat this commonproblem. With this aim “A Comparative Clinical Study to Evaluatethe Effect of *Tarpana Karma* and *Marma* Therapy in Management of *Prathama Patalagata Timira* w.s.r. ToMyopia†was undertaken on 40 clinically diagnosed patients of *Prathama Patalagata Timira/* myopia wererandomly selected from O.P.D / I.P.D. of P.G Departmentof *Shalakya Tantra*, Rishikul Campus, Haridwar.

The clinical study was done dividing the total cases into two groups of 20each.

In Group A- *Tarpana Karma* with *Phalatrikadi* *Ghrita*for 28 days in 2 sittings of 7 days with 7 days gap.

In Group B - *Marma*Therapy was done on 6 *Marma* points *(Apanga, Avarta, Sthapni, Vidhura,Kshipra And Talahridya* of feet) 20 times each point twice a day for 28 days.

Results were assessed in relation to clinical signs and symptoms on the basisof grading and scoring system and data were statistically analyzedby adopting  Wilcoxon’s Signed Rank Testand Mann Whitney test U test for inter group comparison and results wereevaluated in terms of probability (p). *TarpanaKarma* with *Phalatrikadi* *Ghrita* and*Marma* Therapy bothshowedstatistically significant (p<0.05) results on subjective parameters(blurring of vision, eye strain, headache and watering). Statistically significantresults were found in visual acuity and dioptric power in Group A which wereinsignificant in Group B; whereas both the groups showed insignificant resultsin axial length. None of the therapies showed any side effects. It can beconcluded from the study that *Tarpana Karma* with *Phalatrikadi* *Ghrita i*s more efficientin *Prathama Patalagata Timira/* myopia.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-27
• Last Update Posted: 2017-10-08

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• The patients presenting with classical features of Prathama Patalagata Timira/simple myopia after proper screening.
• Patients having -0.25D to -1.5D of vision 3.
• Snellen’s chart reading for distant vision should be equal or less than 6/24.

Exclusion Criteria

• Dwitiya ,Tritiya and Chaturtha Patalagata Timira 2.
• High Myopia or progressive Myopia, Congenital Myopia 3.
• Patients more than -1.5D of vision.
• Refractive errors like Hypermetropia, Astigmatism and other ocular pathologies 5.
• Myopia with systemic diseases like T.B, Hypertension, Diabetes Mellitus.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective parameter:	28 days
Cured : more than 90 % relief in signs and symptoms and no recurrence during follow up study	28 days
Marked improvement: 75% to 90 % improvement in signs and symptoms	28 days
Moderate improvement: 50% to 75% improvement in signs and symptoms.	28 days
Mild improvement: 25% improvement in signs and symptoms.	28 days
Unchanged: less than 25% reduction in signs and symptoms.	28 days

Secondary Outcome Measures

Name	Time	Method
Exacerbation of Signs and symptoms	1 month

Trial Locations

Locations (1)

Rishikul campus, haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Rishikul campus, haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Lotika Bharti

Principal investigator

9596771236

lotikabharti@gmail.com